EUVIMEDEUVIMED entdecken
Open Access

Pharmacokinetics of Intramuscularly Administered Ketamine at Subanaesthetic Dosage in Horses

Zoë Vandaele, Jana Flyps, Charlotte Cuypers, Siegrid De Baere, Mathias Devreese iD, Stijn Schauvliege

Journal of Veterinary Pharmacology and Therapeutics · 2026-07 · 49 (4) · 392-401

DOI: 10.1111/jvp.70070 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Veterinary Pharmacology and Therapeutics, online erschienen am 31.03.2026. Verfasst von Zoë Vandaele und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Large Animal Surgery, Anaesthesia and Orthopaedics, Faculty of Veterinary Medicine, Ghent University, Merelbeke, Belgium. Hauptthemen laut MEDLINE: Analgesics, Ketamine. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Subanaesthetic doses of ketamine (0.5 mg kg −1 ) provide analgesia in several species, but there is limited information on the pharmacokinetics and clinical effects of intramuscularly administered ketamine in horses. This study investigated the pharmacokinetics of ketamine and norketamine, and evaluated clinical effects, ataxia, and vital parameters, following intramuscular and intravenous administration of 0.5 mg kg −1 ketamine in nine healthy horses, using a randomized two‐period crossover design with a 1‐week washout period. Plasma concentrations were analyzed using Ultra‐High Performance Liquid Chromatography–Tandem Mass Spectrometry (UHPLC–MS/MS). Ketamine pharmacokinetic parameters were calculated using a one‐compartment model and norketamine using a noncompartmental model. After intravenous administration ( n = 9), ketamine showed a C max of 525 ± 290 ng mL −1 , an AUC 0–∞ of 85.9 ± 54.7 ng·h mL −1 , and a t 1/2z of 0.1 ± 0.01 h. Following intramuscular administration ( n = 7), ketamine plasma concentrations were below the limit of quantification (< 5 ng mL −1 ) except at a few early timepoints, preventing reliable pharmacokinetic analysis. Norketamine showed a C max of 39.7 ± 32.3 ng mL −1 and a t max of 0.3 ± 0.18 h after intramuscular administration. All horses developed transient, mild‐to‐severe ataxia after intravenous administration, resolving within 15 min. This was not observed after intramuscular administration. Intramuscular ketamine administration (0.5 mg kg −1 ) shows a low systemic bioavailability (< 5%) but is well tolerated and has minimal adverse effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnalgesicsKetamineAnimalsFemaleMaleArea Under CurveCross-Over StudiesHalf-LifeHorsesInjections, IntramuscularInjections, Intravenous

Stichwörter der Autor:innen

ataxiahorseketaminenorketaminepharmacokinetics

Substanzen

AnalgesicsKetamine

Autor:innen und Institutionen

  • Department of Large Animal Surgery, Anaesthesia and Orthopaedics, Faculty of Veterinary Medicine, Ghent University, Merelbeke, Belgium.
  • Department of Pathobiology, Pharmacology and Zoological Medicine, Laboratory of Pharmacology and Toxicology, Faculty of Veterinary Medicine, Ghent University, Merelbeke, Belgium.

ORCID-Profile: Mathias Devreese

Zitieren

APA

Vandaele, Z., Flyps, J., Cuypers, C., De Baere, S., Devreese, M., & Schauvliege, S. (2026). Pharmacokinetics of Intramuscularly Administered Ketamine at Subanaesthetic Dosage in Horses. Journal of Veterinary Pharmacology and Therapeutics, 49(4), 392-401. https://doi.org/10.1111/jvp.70070

Vancouver

Vandaele Z, Flyps J, Cuypers C, De Baere S, Devreese M, Schauvliege S. Pharmacokinetics of Intramuscularly Administered Ketamine at Subanaesthetic Dosage in Horses. Journal of Veterinary Pharmacology and Therapeutics. 2026;49(4):392-401. doi:10.1111/jvp.70070

BibTeX
@article{Vandaele2026,
  author = {Vandaele, Zoë and Flyps, Jana and Cuypers, Charlotte and De Baere, Siegrid and Devreese, Mathias and Schauvliege, Stijn},
  title = {Pharmacokinetics of Intramuscularly Administered Ketamine at Subanaesthetic Dosage in Horses},
  journal = {Journal of Veterinary Pharmacology and Therapeutics},
  year = {2026},
  volume = {49},
  number = {4},
  pages = {392--401},
  doi = {10.1111/jvp.70070}
}
Kostenlos starten →